Evidence map›Paper›PMID 41459783›Full record

ArticleDevelopment (Cambridge, England)2026

Wdr5 and Myc cooperate to regulate formation of neural crest stem cells.

Karlin Compton, Elizabeth Barter, Carole LaBonne

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Karlin ComptonDepartment of Molecular Biosciences, Northwestern University, Evanston, IL 60208, USA.
Elizabeth BarterDepartment of Molecular Biosciences, Northwestern University, Evanston, IL 60208, USA.
Carole LaBonneDepartment of Molecular Biosciences, Northwestern University, Evanston, IL 60208, USA.ORCID 0000-0001-6001-7179

Funding

Neural Crest Ontogeny and the Control of Stem Cell AttributesR01GM116538 · NIGMS · NORTHWESTERN UNIVERSITY · PI LABONNE, CAROLE · 2015 to 2018
$1.2M
Directorate for Biological Sciences 764421National Science Foundation 1764421NIGMS NIH HHS R01 GM116538NIGMS NIH HHS R01GM116538Northwestern UniversitySimons Foundation SFARI 597491-RWC
6 · The paper itself

Abstract

Wdr5, a multifunctional scaffolding protein, with established roles in chromatin regulation and pluripotency, but its functions in early development remain poorly understood. Here, we show that Xenopus wdr5 is expressed in blastula stem cells and enriched in neural crest cells. Depletion of wdr5 abolished neural crest gene expression in embryos and in reprogrammed explants while expanding neural plate border and neural plate domains. Gain-of-function experiments revealed striking dose-dependent effects: low Wdr5 enhanced neural crest formation, whereas high levels suppressed it, suggesting a requirement for precise stoichiometry with interacting partners. We identify Myc as an essential co-factor for Wdr5 in neural crest - Wdr5 and Myc physically interact and co-expression at defined ratios rescues neural crest formation. We further show that the Wdr5 WBM site is required for Myc-dependent activation of neural crest genes, whereas the WIN site regulates myc expression itself; both domains are necessary to rescue wdr5 depletion. These findings reveal that Wdr5 orchestrates neural crest development through multiple, domain-specific mechanisms, integrating stoichiometric control with partner-specific transcriptional regulation, and underscores the importance of precise co-factor ratios in cell fate decisions.

Indexed as

Neural CrestNeural Stem CellsProto-Oncogene Proteins c-mycXenopus laevisXenopus ProteinsAnimalsCell DifferentiationGene Expression Regulation, DevelopmentalProto-Oncogene Proteins c-mycXenopus ProteinsMycNeural crestPluripotencyStem cellWdr5Xenopus

Identifiers

PMID41459783
PMCPMC12863299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.